1.5000
-0.0600
(-3.85%)
At close: January 24 at 4:00:00 PM EST
1.5900
+0.09
+(6.00%)
Pre-Market: 8:36:41 AM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -0.02 | 0 | -0.1 | -0.23 |
Low Estimate | -0.02 | 0 | -0.1 | -0.23 |
High Estimate | -0.02 | 0 | -0.1 | -0.23 |
Year Ago EPS | -- | -- | -- | -0.1 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 1 | -- | 1 | 1 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | 0.00% |
Earnings History
Currency in USD | 9/30/2024 |
---|---|
EPS Est. | -0.02 |
EPS Actual | -0.1 |
Difference | -0.08 |
Surprise % | -400.00% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -0.02 | 0 | -0.1 | -0.23 |
7 Days Ago | -0.02 | 0 | -0.1 | -0.23 |
30 Days Ago | -0.02 | 0 | -0.1 | -0.23 |
60 Days Ago | -0.02 | 0 | -0.1 | -0.23 |
90 Days Ago | -0.02 | 0 | -0.1 | -0.23 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
KAPA | -- | -- | -- | -130.00% |
S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
Maintains | D. Boral Capital: Buy to Buy | 1/22/2025 |
Maintains | D. Boral Capital: Buy to Buy | 11/14/2024 |
Initiated | EF Hutton: Buy | 10/14/2024 |
Related Tickers
SLRX Salarius Pharmaceuticals, Inc.
2.5800
-5.49%
PHIO Phio Pharmaceuticals Corp.
2.2100
-5.56%
ERNA Eterna Therapeutics Inc.
0.5661
-2.40%
HOTH Hoth Therapeutics, Inc.
1.3600
-7.48%
AEON AEON Biopharma, Inc.
0.1383
+8.05%
AZTR Azitra, Inc.
0.2679
+6.27%
SPRC SciSparc Ltd.
0.5772
-1.82%
ZVSA ZyVersa Therapeutics, Inc.
1.4808
-1.93%
ONCO Onconetix, Inc.
0.4800
0.00%
DRMA Dermata Therapeutics, Inc.
1.1700
-1.68%